Gold nanoparticles (AuNPs) have been investigated as a promising reagent for cancer therapy in various fields. In the meantime, cold atmospheric plasma has shown exquisite selectivity towards cancer cells. In this paper, we demonstrate that there is a synergy between gold nanoparticles and cold atmospheric plasma in cancer therapy. Specifically, the concentration of AuNPs plays an important role on plasma therapy. At an optimal concentration, gold nanoparticles can significantly induce glioblastoma (U87) cell death up to a 30% overall increase compared to the control group with the same plasma dosage but no AuNPs applied. The reactive oxygen species (ROS) intensity of the corresponding conditions has a reversed trend compared to cell viability. This matches with the theory that intracellular ROS accumulation results in oxidative stress, which further changes the intracellular pathways, causing damage to the proteins, lipids and DNA. Our results show that this synergy has great potential in improving the efficiency of cancer therapy and reducing harm to normal cells.
Introduction
In the last two decades, gold nanoparticles (AuNPs) have emerged as a strong adjunct used by scientists and physicians in the treatment of a variety of malignancies [1] . These nanoparticles have been investigated in diverse fields for many therapies such as a drug carrier [2] , a photothermal agent [3] , a contrast agent [4] and as a radiosensitizer [5] . These investigations have all been centred on the goal of combining current treatments with nanotechnology to provide synergistic effects. The mechanism of action for these combined therapies is unique for each type of treatment. Through this research, the use of nanotechnology displays a multitude of applications to cancer treatment through a vast number of pathways.
Plasma is an ionized form of matter that makes up the majority of the known universe. It is a form of ionized gas that generally occurs in very high temperatures in experimental laboratories. Through the recent success in the plasma community, researchers have been able to decrease the ion temperature of atmospheric plasma to around room temperature [6] . It should be noted that while the temperature of the ions in the plasma is low, that the electron temperature is still relatively high; this is negligible in macroscopic experiments since the magnitude of the electron effect is much smaller in comparison to the ion. In that sense, plasma can be separated into two areas by ion temperature: thermal and non-thermal. Thermal plasma has biomedical applications in surgery for the cutting of tissue and the coagulation of blood [7] . Non-thermal, or cold, plasma operates by a different reaction mechanism, which generally does not lead to the necrosis of cells. The reactive ionized species is the main component of the cold plasma jet that provides for therapeutic effects, not only with cancer, but also with biological disinfection [8] , viral destruction [9] and wound healing [10] .
Cold atmospheric plasma (CAP) has been successfully shown to selectively induce apoptosis in cancer cells, while leaving normal cells relatively unharmed [11] . The therapeutic effect is reported both with in vitro and in vivo experiments [12] . This effect is best understood by the composition of the CAP jet which includes reactive oxygen species (ROS), reactive nitrogen species (RNS) and charged particles. Studies have sought out to understand the effect of the cold plasma jet through many biological applications, for example: cell death studies [13] , cell cycle studies [14] and cell adhesion studies [15] . These results all converge on the idea that the reactive nature of species in the CAP jet provide for a multitude of cellular dysfunction.
CAP has been extensively studied in the treatment of cancer, with the goal of maximizing tumour cell death and minimizing the therapy's effect to healthy tissue [14, 16] . Since cold plasma is a combination of light energy, reactive chemicals and charged particles, it is possible that synergistic effects exist between CAP and gold nanoparticles. Current success in nanoparticle-cancer research has allowed scientists to develop special antibody-conjugated gold nanoparticles which can target cancer cells [17, 18] , which may promote the selectivity of cold plasma. With this idea, the effect of the synergy between the AuNPs and CAP is studied in this paper.
The cancer cell line chosen for this study was stage IV glioblastoma multiforme. The prognosis of this form of cancer is very grim, which means there is a large need for effective selective cancer therapies. This line was also chosen because it takes a larger 'plasma dose' than other cell lines to cause a substantial amount of cell death. This is favourable to show the synergistic effects over a range of dosages, as compared to control.
Currently, the literature surrounding this synergistic effect is extremely limited. Kim et al [19] was the first to publish their work in this new interdisciplinary area. They achieved a five-fold increase in melanoma cell death over the case of the CAP alone by using air plasma with gold nanoparticles bound to anti-FAK antibodies. A detailed review [20] was published by Kong et al in 2011, demonstrating the strengths and weaknesses of plasma medicine and nanomedicine as a stand-alone technology, then providing a critical analysis of some of the major opportunities enabled by synergizing nanotechnology and plasma technology. This study seeks to further expand the knowledge surrounding the synergistic effects between CAP jet and gold nanoparticles. 100 nm gold nanoparticles were used in this study, combined with CAP to enhance the therapeutic effects on glioblastoma cells. The concentration of gold nanoparticles in the experimental setup was varied, and the subsequent endogenous ROS concentration and cell viability were studied. The synergistic effect of AuNPs and CAP on the in vivo glioblastoma cancer therapy is shown in the following sections.
Materials and methods

CAP configuration
The cold plasma device invented at the George Washington University has been described elsewhere [13] . In general, it has a configuration of central powered electrode of 1 mm diameter and a grounded outer electrode wrapped around the outside of a 4.5 mm diameter quartz tube, powered by ac high voltage (2-10 kV, ∼30 kHz). Industrial grade helium (from Airgas) was used as feeding gas. The flow rate was maintained at 4.7 l min −1 . The output voltage was set to 3.16 kV. The power supply was around 5 W. The plasma jet was applied directly to the cancer cells with a distance of 25 mm between the nozzle and the culture media.
Cell culturing
The human brain glioblastoma cancer cell line (U87) was obtained from the American Type Culture Collection (Manassas, VA).
Cells were cultured in Dulbecco's Modified Eagle Medium (Life Technologies) supplemented with 10% (v/v) foetal bovine serum (Atlantic Biologicals) and 1% (v/v) penicillin and streptomycin (Life Technologies). Cultures were maintained at 37
• C in a humidified incubator containing 5% (v/v) CO 2 . Cells were observed under a Nikon Eclipse TS100 inverted microscope.
Gold nanoparticles
AuNPs of 100 nm in diameter were used in this study (purchased from Nanopartz). The original concentration of the AuNPs stock solution was 5.7 × 10 11 ml −1 . The concentration of AuNPs mentioned in the following text (0-2 µl ml −1 ) means 0-2 µl of the original stock solution were added to 1 ml media. The AuNP incubated U87 cells were prepared as follows. U87 cells were seeded on the 96 well plates (for intracellular ROS measurement) or glass-bottom dishes (for confocal microscopy) at a confluence of 40% (around 50 000 cells per ml). After 24 h incubation to allow cell adhesion, desired concentration of AuNPs (0-2 µl ml −1 ) were added into cells, and incubated together for 1 or 24 h to allow penetration. The cells with AuNPs were then treated with cold plasma for 30 s.
Cell viability assay
Cell viability was monitored using the MTT assay (Sigma-Aldrich, M2128), which is a colorimetric assay for measuring the activity of mitochondria and cellular dehydrogenase enzymes that reduce 3-[4,5-dimethylthiazol-2-yl]-2,5-dyphenyltetrazolium bromide, MTT, to its insoluble formazan, giving a purple hue. Cells were plated into 96-well flat-bottomed microplates in 100 µl medium per well. Confluence of each well was ensured to be at ∼40%. Cells were then incubated for one day to ensure a proper cell adherence and stability. Cells were rinsed with phosphate buffered saline (PBS, Lonza 17-512F), replaced with a fresh medium before treated with cold plasma. After an additional incubation at 37
• C for 24, 48 and 72 h post-plasma treatment, original culture medium was aspirated, 100 µl of MTT solution per well (7 mg thiazolyl blue tetrazolium blue in 10 ml medium for one plate) was added into each well. Reactions were maintained for 3 h at 37
• C. The MTT solution was aspirated and 100 µl of MTT solvent (0.4% (v/v) HCl in anhydrous isopropanol) was added to each well to dissolve formazan crystals. Reactions were monitored by the Synergy H1 Hybrid Multi-Mode Microplate Reader at 570 nm. The entire set of experiments was repeated three times.
Atomic force microscopy (AFM)
AFM (Asylum, MFP-3D, California) was used to characterize the surface topography of the cell samples. AFM images were recorded in phosphate buffer solution (PBS) at room temperature. All measurements were done in a contact mode using sharpened silicon nitride probes TR400PSA (Veeco-OTR4, Olympus, Japan) with two sets of two triangular levers. Resonance frequency of the shorter, 100 µm lever is 21-52 kHz and has a force (spring) constant of 0.02-0.23 N m −1 ; for the longer, 200 µm lever the resonant frequency is 7-15 kHz and has a force constant of 0.01-0.05 N m −1 . The image data were collected in the deflection mode with the loading force of 1 to 5 nN at scan rate of, typically, 0.9 Hz. The images obtained in the deflection mode enhance structural details.
Before imaging, cells were fixed and dehydrated in order to simplify the imaging process. Cell fixation was accomplished by treating the coverslips with 0.5% solution of glutaraldehyde for 5 min then washing with 10mM PBS, pH7.4. After fixation, cells were dehydrated in the different % of ethanol solution according to standard protocol, described elsewhere [21] . Dehydration of cells was a key step in order to lower the average height of cells and make topography imaging possible. Fixed cells were imaged in the PBS.
Intracellular ROS measurement
Chloromethyl-2 ,7 -dichlorodihydrofluorescein diacetate (CM H2DCFDA) were obtained from Life Technologies. U87 cells were seeded on the 96 well plates at a confluence of 40%. After full attachment, cells were loaded with 5µM CM H2DCFDA dye following the protocol provided by Life Technologies and incubated at 37
• C. After 15 min, fresh media were added and cells were put back into incubator for 3 h to recover. After full recovery, AuNPs were added into cells following the steps in the above 'Gold nanoparticles' section. The stained AuNP incubated cells were then treated with plasma for 30 s and put back into incubator. 1 or 24 h after the treatment, ROS intensity was monitored by the Synergy H1 Hybrid Multi-Mode Microplate Reader at Ex/Em: 495/520 nm. The spectrometer and the detection probe were purchased from Stellar Net Inc. The optical probe was place at a distance of ∼2.5 cm in front of the extension tube, coherent with the real distance between the plasma jet nozzle and the cells during treatment. Integration time of the collecting data was set to 100 ms.
Statistical analysis
Results were plotted using a Microsoft Excel software (2011 for Mac) as mean ± standard deviation. Student t-test was used to check the statistical significance (*p<0.05, **p<0.01, ***p<0.001).
Results and discussion
The cells were cultured with AuNPs for 1 or 24 h to allow different degrees of penetration. Figure 1 AFM has been widely applied to biological samples because of the combination of high resolution and the ability to work under biological conditions. The AFM images are different from those obtained using conventional optical microscopy. AFM images of cells shows combination of surface and mechanical information. The AFM technique is particularly well suited to studying the membrane surface and the cytoskeleton [22] .
AFM micrographs revealed important information on the shape and cell adhesion. In order to assess differences in morphology, the morphological appearances of the adhered glioblastoma (U87) cells were imaged by AFM only 1 h after plasma treatment and incubation in solution with different nanoparticle concentration, to catch the initial moments of the nanoparticle penetration. AFM images of fixed human glioblastoma cells were obtained at different scan sizes. Cells were grown to near required confluence on glass coverslips and subsequently imaged in 10mM PBS, pH 7.4. Based on AFM images, substantial differences between the samples can be observed. Figure 2 shows the AFM images of U87 cells at lower magnifications, the cell shape and morphology is clearly visible. On the control of plasma untreated cells without nanoparticles in the solution, U87 cells are extensively spread with raised nuclear regions, microvilli and blebs are observed on the surface as well as active margins in terms of ruffling. After plasma treatment for 30 s and the concentration of 0.5 µl ml −1 nanoparticles in the solution, cells are both shrunken and rounded up with predominantly raised nuclear nanoparticle solution are thickened and very active, also the microvilli and the blebs can be easily noticed on the surface of the cells. It can be noticed that it is not necessary to use higher concentration of nanoparticles in the solution to favour and increase the cell death after plasma treatment. The results indicate the fundamental importance of gold nanoparticle concentration in the solution, when combined with plasma treatment for glioblastoma cancer therapy. To look closer on the cell membrane surface, AFM images of higher magnifications were performed. Figure 3 shows high-magnification images of cell membrane and cytoskeleton with scan size approximately 5 × 5 µm 2 . The extensive cytoskeletal network under the cell membrane can be observed. If we compare cell membrane surface, stark differences can be observed in the cell membrane topography. Cell membrane surface with no nanoparticles in the medium (c = 0 µl ml −1 ) is very flat, small pores in the membrane can be observed, no granular elevations. Looking closer on the picture with 0.5 µl ml −1 nanoparticle concentration, granular elevations can be observed, which are thought to be nanoparticles agglomerated in small clusters, after penetrating in the cell. Also, non-negligible amount of agglomerated gold nanoparticle can be observed on the sample surface ( figure 2) . On the contrary, we do not observe any granular elevation with a concentration of 2 µl ml −1 in solution. At this concentration, there are huge pores on the cell membrane surface are present. According to the low magnification AFM image (figure 2) at the same nanoparticle concentration of 2 µl ml −1 , most of the nanoparticles penetrate inside the cell and are not concentrated on the cell membrane surface, as in the case of 0.5 µl ml −1 concentration. Furthermore, it is thought that some nanoparticles agglomerate already in the medium, before penetrating into the cell. It is well known that nanoparticles tend to agglomerate preferable at higher concentrations, when in solution [23] . Unless clusters are too big, they can easily penetrate in the cell through cell membrane channels or the pores in the cell membrane and accumulate in the cell organelles or cytoplasm. This can be explained with the relatively large pores, observed on the cell membrane surface, when in solution with 2 µl ml −1 nanoparticle concentration. These results also explain well why the apoptotic effect [24] of our plasma on the U87 cells was much stronger in the concentration of 0.5 µl ml −1 gold nanoparticles in the solution, than at 2 µl ml −1 concentration. This suggests that AuNPs in the media accelerate the absorption of exogenous ROS and RNS produced by plasma, killing the cancer cells by regulating the various pathways in the cells [11] . Figure 4 shows a typical spectrum of helium cold plasma jet interacting with the ambient air with output voltage of 3.16 kV and a helium flow rate of 4.7 l min −1 . The identification of emission lines and bands was mainly according to [25] . It is shown that O (777 nm), OH (309 nm), N + 2 (391 nm), N 2 or NO lines (316, 337, 358, 427.5 nm) are the domain species of the spectra. The reactive species produced by cold plasma are defined as exogenous ROS and RNS, in comparison to the endogenous ROS and RNS which are produced by cells themselves.
To understand how cells react to plasma treatment with various concentration/incubation time of AuNPs, MTT assays and endogenous ROS measurements were performed the relative higher cell viability (figure 6 blue line) showed a direct weakened plasma effect. The statistical analysis showed that the viabilities of cells with 0.2, 0.5 and 1 µl ml −1 AuNP incubation for 1 h were statistically significant than non-AuNP incubated cells (0 µl ml −1 ), while the viabilities of cells with corresponding AuNP concentration incubated for 24 h were not statistically significant than the cells with no AuNPs.
It has been recognized by both our lab and other research groups [26, 27] that culture media is playing an important role in the plasma-cancer interaction. This can be proved by indirect plasma treatment (cells are treated by plasma-activated media rather than directly treated by plasma). The recovery of both direct and indirect plasma-treated cancer cells was significantly lower after treatment than the control group and was further decreased with time [27] , suggesting that media can carry the exogenous ROS and RNS to cells. Along with figures 1-6, the apoptotic effect of our plasma was much stronger with AuNPs in the media (1 h incubation) than all of them in the cells (24 h incubation), it can be concluded that the AuNPs in the media accelerate the absorption of exogenous ROS and RNS produced by plasma, yet the concentration of AuNPs is an important variable to control since it is not linear. When the concentration of gold nanoparticles is above a threshold level, it decreased cell death and intracellular ROS. This can be rationalized by the fact that charged particles from the plasma playing an important role in intracellular ROS creation and that the nanometallic material is detracting from cell-based reactions. This can either be at a chemical level or a physical level; this exact mechanism has yet to be discovered. However, from our results, 0.5 µl ml −1 is the optimal concentration of AuNPs to achieve the best synergistic effect.
The temperature of the cold plasma jet remains near room temperature even after running for a few hours. The cell viability was compared to the plasma-treated non-nanoparticle incubated cells for the same time duration; therefore, the temperature of plasma should not be the cause of decrease of cell viability. Although it is still controversial in the literature with respect to the mechanism of plasma killing cancer cells [28] , it is commonly acknowledged that intracellular biochemistry is triggered by plasma, leading to cell death [29] [30] [31] . From figures 5 and 6, the endogenous ROS intensity of the corresponding conditions has a reversed trend compared to cell viability for both incubation times. This matches with the theory that intracellular ROS accumulation results in oxidative stress, which further changes the intracellular pathways, causing damage to the proteins, lipids and DNA [30, 32] .
As mentioned in the Introduction, the U87 cell line is a very robust cancer type. This line was chosen because it takes longer plasma treatment time than other cell lines to cause a substantial amount of cell death. From the results shown above, the synergistic effects can help induce up to 30% more cell death with the same plasma dosage applied, as compared to control.
Conclusion
The current study reveals that the synergy between gold nanoparticles and cold atmospheric pressure plasma is highly dependent on the concentration of AuNPs. At an optimal concentration, gold nanoparticles can significantly induce the cell death up to 30% overall increase with the same plasma dosage applied. Our results show that this synergy has great potential in improving the efficiency of cancer therapy and reducing the harm to normal cells.
